Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PARICALCITOL CAPSULES safely and effectively. See full prescribing information for PARICALCITOL CAPSULES. PARICALCITOL capsules, for oral use Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD).
- generic_name
- paricalcitol
- product_names
- Paricalcitol
- ndc
- 65862-936, 65862-937, 65862-938, 65862-936-30, 65862-937-30, 65862-938-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en